Physician profile
Stephan Forstot
NPI 1881687432
$6,925.69
in general payments reported to CMS, 2019-2025
22 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,128 · 2020: $72.68 · 2021: $3,871 · 2022: $234 · 2023: $20.63 · 2024: $484 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,043.37 | 2021 | |
| Eyevance Pharmaceuticals LLC | $1,659.95 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $1,374.30 | 2021-2022 | |
| Allergan, INC. | $579.41 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $265.05 | 2019-2025 | |
| Aerie Pharmaceuticals, INC. | $191.91 | 2019-2021 | |
| Harrow Eye, LLC | $180.04 | 2024 | Vevye |
| Dompe US, INC. | $158.65 | 2019-2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.83 | 2019-2020 | |
| Ocular Therapeutix, INC. | $47.67 | 2021-2022 | |
| Abbvie INC. | $42.45 | 2022 | |
| Alcon Vision LLC | $34.67 | 2025 | Clareon |
| Biotissue Holdings INC. | $33.49 | 2022 | |
| Glaukos Corporation | $32.95 | 2020-2023 | |
| Shire North American Group INC | $24.91 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $24.82 | 2024 | Miebo |
| Rxsight INC | $24.06 | 2022 | |
| Sight Sciences, INC. | $16.40 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.53 | 2022 | |
| Katena Products, INC. (Dba Corza Medical) | $11.21 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Forstot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.